{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:27:26Z","timestamp":1767338846092,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1124\/mol.105.014225","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T03:34:43Z","timestamp":1118806483000},"page":"808-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["CYP3A5 mRNA Degradation by Nonsense-Mediated mRNA Decay"],"prefix":"10.1016","volume":"68","author":[{"given":"Florent","family":"Busi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Cresteil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.105.014225_bib1","doi-asserted-by":"crossref","first-page":"38379","DOI":"10.1074\/jbc.M404949200","article-title":"The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR)","volume":"279","author":"Burk","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.105.014225_bib2","doi-asserted-by":"crossref","first-page":"10881","DOI":"10.1093\/nar\/16.22.10881","article-title":"Multiple sequence alignment with hierarchical clustering","volume":"16","author":"Corpet","year":"1988","journal-title":"Nucleic Acids Res"},{"key":"10.1124\/mol.105.014225_bib3","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/0006-2952(79)90224-7","article-title":"Effect of microsomal preparations and induction on cytochrome P-450-dependent monooxygenases in fetal and neonatal rat liver","volume":"28","author":"Cresteil","year":"1979","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.105.014225_bib4","first-page":"386","article-title":"Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation","volume":"54","author":"Cresteil","year":"1994","journal-title":"Cancer Res"},{"key":"10.1124\/mol.105.014225_bib5","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0026-895X(24)12850-7","article-title":"cDNA cloning and initial characterization of CYP3A43, a novel human cytochrome P450","volume":"59","author":"Domanski","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.014225_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/85417","article-title":"CYP3A Genetics in drug metabolism","volume":"7","author":"Eichelbaum","year":"2001","journal-title":"Nat Med"},{"key":"10.1124\/mol.105.014225_bib7","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.105.014225_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/sj.tpj.6500218","article-title":"CYP3A5 genotype did not impact on nifedipine disposition in healthy volunteers","volume":"4","author":"Fukuda","year":"2004","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/mol.105.014225_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00008571-200103000-00002","article-title":"Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene","volume":"11","author":"Gellner","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.105.014225_bib10","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2337\/diabetes.53.2.500","article-title":"Messenger RNA transcripts of the hepatocyte nuclear factor-1alpha gene containing premature termination codons are subject to nonsense-mediated decay","volume":"53","author":"Harries","year":"2004","journal-title":"Diabetes"},{"key":"10.1124\/mol.105.014225_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0009-9236(03)00168-1","article-title":"Genetic polymorphisms of the CYP3A4, CYP3A5 and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus","volume":"74","author":"Hesselink","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/mol.105.014225_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1403","article-title":"Nonsense-mediated decay approaches the clinic","volume":"36","author":"Holbrook","year":"2004","journal-title":"Nat Genet"},{"key":"10.1124\/mol.105.014225_bib13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1124\/dmd.104.001313","article-title":"Evidence of significant contribution from CYP3A5 to hepatic drug metabolism","volume":"32","author":"Huang","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.105.014225_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-200112000-00005","article-title":"The genetic determinants of the CYP3A5 polymorphism","volume":"11","author":"Hustert","year":"2001","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.105.014225_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1006\/bbrc.1996.0618","article-title":"Detection of CYP3A5 allelic variant: a candidate for the polymorphic expression of the protein?","volume":"221","author":"Jounaidi","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.105.014225_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.clpt.2004.01.013","article-title":"CYP3A5 genotype has a dose-dependent effect on ABT-773 plasma levels","volume":"75","author":"Katz","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/mol.105.014225_bib17","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/dmd.30.10.1108","article-title":"Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA","volume":"30","author":"Koch","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.105.014225_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86882","article-title":"Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression","volume":"27","author":"Kuehl","year":"2001","journal-title":"Nat Genet"},{"key":"10.1124\/mol.105.014225_bib19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1432-1033.1997.00625.x","article-title":"Expression of CYP3A in the human liver\u2014evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth","volume":"247","author":"Lacroix","year":"1997","journal-title":"Eur J Biochem"},{"key":"10.1124\/mol.105.014225_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/hmg\/ddg011","article-title":"Nonsense mediated decay downregulates conserved alternatively spliced ABCC4 transcripts bearing nonsense codons","volume":"12","author":"Lamba","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1124\/mol.105.014225_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/00008571-200308000-00004","article-title":"Genetic findings and functional studies of human CYP3A5 single nucleotide polymorphisms in different ethnic groups","volume":"13","author":"Lee","year":"2003","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.105.014225_bib22","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0026-895X(24)23143-6","article-title":"Loss of Cyp1a1 messenger RNA expression due to nonsense-mediated decay","volume":"60","author":"Lei","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.014225_bib23","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1124\/mol.62.1.162","article-title":"Coregulation of CYP3A4 and CYP3A5 and contribution to hepatic and intestinal midazolam metabolism","volume":"62","author":"Lin","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.014225_bib24","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00007890-200212150-00002","article-title":"Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome P4503A5 and P-glycoprotein correlate with dose requirement","volume":"74","author":"Macphee","year":"2002","journal-title":"Transplantation"},{"key":"10.1124\/mol.105.014225_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1074428","article-title":"Separable roles for Rent1\/hUpf1 in altered splicing and decay of nonsense transcripts","volume":"298","author":"Mendell","year":"2002","journal-title":"Science (Wash DC)"},{"key":"10.1124\/mol.105.014225_bib26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2133\/dmpk.17.491","article-title":"CYPalleles: a web page for nomenclature of human cytochrome P450 alleles","volume":"17","author":"Oscarson","year":"2002","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/mol.105.014225_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00008571-200007000-00005","article-title":"Two linked mutations in transcriptional regulatory elements of the CYP3A5 gene constitute the major genetic determinant of polymorphic activity in humans","volume":"10","author":"Paulussen","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.105.014225_bib28","first-page":"365","article-title":"Primer3 on the WWW for general users and for biologist programmers","volume":"132","author":"Rozen","year":"2000","journal-title":"Methods Mol Biol"},{"key":"10.1124\/mol.105.014225_bib29","first-page":"2012","article-title":"Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans","volume":"6","author":"Santos","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1124\/mol.105.014225_bib30","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1124\/dmd.30.12.1491","article-title":"Pharmacokinetics of midazolam and 1\u2032-hydroxymidazolam in Chinese with different CYP3A5 genotypes","volume":"30","author":"Shih","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.105.014225_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1124\/jpet.103.054841","article-title":"Developmental expression of the major human hepatic CYP3A enzymes","volume":"307","author":"Stevens","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.105.014225_bib32","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/emboj\/20.7.1785","article-title":"SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs","volume":"20","author":"Sureau","year":"2001","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/mol.105.014225_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1124\/dmd.31.6.755","article-title":"Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism","volume":"31","author":"Westlind-Johnsson","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/mol.105.014225_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/35067025","article-title":"The cap-to-tail guide to mRNA turnover","volume":"2","author":"Wilusz","year":"2001","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1124\/mol.105.014225_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00008571-200404000-00007","article-title":"Single nucleotide polymorphism characterization by MRNA expression imbalance assessment","volume":"14","author":"Wojnowski","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1124\/mol.105.014225_bib36","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1097-2765(03)00502-1","article-title":"Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay","volume":"13","author":"Wollerton","year":"2004","journal-title":"Mol Cell"},{"key":"10.1124\/mol.105.014225_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0026-895X(25)09114-X","article-title":"Identification of a polymorphically expressed member of the human cytochrome P-450III family","volume":"36","author":"Wrighton","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.105.014225_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1034\/j.1600-6143.2003.00077.x","article-title":"Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms","volume":"3","author":"Zheng","year":"2003","journal-title":"Am J Transplant"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24052258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24052258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.105.014225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T12:06:28Z","timestamp":1739966788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24052258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0026895X24052258"],"URL":"https:\/\/doi.org\/10.1124\/mol.105.014225","relation":{},"ISSN":["0026-895X"],"issn-type":[{"type":"print","value":"0026-895X"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CYP3A5 mRNA Degradation by Nonsense-Mediated mRNA Decay","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.105.014225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2005 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}